以前列腺对比剂滞留(PCR)作为前列腺动脉栓塞术手术终点的应用
技术成功率98.8%,临床成功率96.4%,PCR充分者临床成功率显著更高,IPSS、QoL及前列腺体积等指标随访均显著改善。
要点
- PAE术中应以栓塞后CBCT上PCR>75%作为手术终点,不足时追加栓塞。
- PCR充分者临床成功率显著更高,提示更完全的栓塞可改善疗效。
- 术后1、3、6、12个月IPSS与QoL显著改善,3、6、12个月前列腺体积及残余尿显著下降。
核心结论
- 以PCR充分性作为PAE手术终点,可能实现更完全的栓塞,从而获得更高的临床成功率。
研究设计与样本
- 栓塞主要前列腺动脉后评估即刻CBCT上PCR,若不充分则追加栓塞;技术成功定义为全前列腺对比剂染色>75%。
- 临床成功按CIRSE实践标准判定。
关键影像表现/征象
- 栓塞后即刻锥形束CT上评估前列腺对比剂滞留(PCR),以全前列腺腺体对比剂染色>75%作为PCR充分的技术成功标准。
诊断标准与关键数值
- 技术成功(PCR充分)定义为全前列腺腺体对比剂染色>75%。
- 技术成功率为98.8%,临床成功率为96.4%。
- PCR充分患者的临床成功率显著高于PCR不充分者。
- 轻度(Clavien-Dindo I/II级)和中度(III级)并发症发生率分别为12.1%和3.6%。
临床应用与阅片要点
- PAE术中应行栓塞后即刻CBCT评估PCR,若染色范围不足>75%应追加栓塞,而非仅依赖透视下动脉对比剂停滞。
- 报告时应描述PCR是否充分及追加栓塞情况,并记录并发症分级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The failure rate following prostate artery embolization (PAE) is around 20%, which may in part result from inadequate embolization. Prostate contrast retention (PCR) adequacy on immediate post-embolization cone-beam CT may provide better assessment of embolization completeness than arterial contrast stasis seen on fluoroscopy alone. The aim of this study was to evaluate outcomes of PAE using PCR adequacy as the procedural endpoint.
METHODS: A retrospective cohort study of all PAE cases using this technique at a single large volume center was conducted. Following initial embolization of the main prostatic arteries, if PCR was inadequate, additional embolization was performed. Technical success (adequate PCR) was defined as > 75% global prostate gland contrast staining. Clinical success was determined in accordance to CIRSE standards of practice.
RESULTS: One hundred sixty-five patients (mean age 68 ± 8.4 years) underwent PAE from June 2017 to March 2019. Technical and clinical success rates were 98.8% and 96.4% respectively. Clinical success rate was significantly higher in patients with adequate PCR. International Prostate Symptom Scores (IPSS) and Quality of Life (QoL) scores significantly improved at 1-, 3-, 6-, and 12-month follow-up when compared to baseline. Prostate volume (PV) and post-voiding residual bladder volume were significantly reduced at 3, 6, and 12 months in comparison to baseline. Mild (Clavien-Dindo grade I/II) and moderate (grade III) complication rates were 12.1% and 3.6% respectively.
CONCLUSIONS: By using PCR adequacy as a guide to determine the procedure endpoint for PAE, it may be possible to achieve more complete embolization and thus higher clinical success rates.
KEY POINTS: • By using PCR adequacy as a guide to determine the procedure endpoint for PAE, it may be possible to achieve more complete embolization and thus higher clinical success rates.
引用
- Hakimé A, Tun JK, Haab F, et al. Using prostate contrast retention (PCR) as the procedural endpoint in prostatic artery embolization for benign prostatic hyperplasia. Eur Radiol. 2021. PMID: 34050801. doi:10.1007/s00330-021-08063-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。